About: http://data.cimple.eu/news-article/be8d36798209657b1a76c581de374ed3a3efff5c2e0dede0fac81646     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • The battle against Covid-19 has delivered not just a vaccine at record speed but also a spike in demand for the billions of syringes needed to administer it. One German factory is already busily churning out the little plastic tubes and is confident global needs can be met. "There won't be a shortage of syringes, even if we are facing a big challenge," said Otto-Philipp Braun, co-director of Almo, Germany's leading syringe manufacturer. At the company's production site in the central German town of Bad Arolsen, the loud hum of machinery fills the hall. Employees man the assembly lines, wearing masks, hair nets and occasionally ear plugs. They churn out disposable syringes 24 hours a day, seven days a week, destined for use in Germany and more than 140 other countries around the world. One machine moulds high-quality plastic granules into thin, one-millilitre syringes, while another spits out the pistons that fit snugly inside the cylinder and are needed to push out the vaccine. The plastic piston is green, matching the logo of German parent company B.Braun, a giant in the medical devices industry and still owned by the Braun family. A total of 64 syringes with pistons are assembled every 13 seconds. Every year, Almo churns out more than two billion syringes of various kinds. The needles that can be added to the injection devices are produced by a B.Braun subsidiary in Malaysia. The company intends to spend 30 million euros on an additional assembly line, partly to cope with increased demand for the Covid-19 jabs. The first orders have already rolled in from Germany's BioNTech, whose vaccine developed with US giant Pfizer is already being administered in some countries, and from CureVac, another German company whose vaccine candidate is in final stage trials. "We can produce 270 million syringes of one millilitre next year, and if necessary an extra 200 million from 2022," Braun told AFP. Taking into account larger-size syringes that are also used for vaccine injections, Almo has orders for some 500 million units for 2020 and 2021. Its main rival, US behemoth Becton, Dickinson and Company (BD), earlier this week said it had received orders for more than a billion injection devices globally as part of Covid-19 inoculation efforts. bur-jpl/mfp/hmn/bmm
schema:headline
  • German factory races to churn out Covid-19 syringes
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...romotesConspiracy
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software